| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |